VisEn Medical Inc. of Woburn, Mass., has entered into a joint research program with Eli Lilly and Co. of Indianapolis to find applications for the former company’s fluorescence in vivo imaging technologies in the latter’s research programs. The collaboration should offer VisEn an opportunity to develop products and expand use of its in vivo fluorescence probes, fluorescence molecular tomography and other systems in drug development.